On Wednesday, researchers announced that they had “positive data” in regards to a potential treatment for COVID-19. Clinical trials for Gilead Sciences’ antiviral drug remdesivir, which was developed to treat Ebola, showed a “clear-cut positive effect in diminishing time to recover,” according to Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases.
Publisher: Refinery29 | Author: Britni De La Cretaz